SecBot SecBot

DRMAW

Dermata Therapeutics, Inc.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001853816 Biotech & Drug Discovery
—
Market cap
$2.4K
Nano cap
1 year
−79.9%
from $3.76 · Oct 28
30 days
−32.6%
from $1.12
52-week range
$0.6630–3.76
−80% from high · low Oct 14
Avg volume 20D
8.77M
Oct 15 spike 170.52M
Short interest
401
≈0.0% of shares · −16.5%
Days to cover
1.0
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
3
analyzed by SecBot
SecBot read BEARISH 3 reports · latest
Balance 1 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 2/3
Strongest BEARISH The SEC declared effective Dermata Therapeutics' S-3 shelf registration (File No. 333-291740) on May 29…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 0 trimmed or exited.

  • Short sellersCOVERING

    Short interest −16.5% to 401 shares. 1.0 days to cover, ≈0.0% of shares.

  • TrendDOWNTREND

    34% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGADD1,804$18.00
UBS Group AGTRIM1,279$22.00
UBS Group AGTRIM1,880$34.00
UBS Group AGTRIM2,617$44.00
BANK OF AMERICA CORP /DE/TRIM100$1.00

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 18, 2026
Listing
Delisted: DRMAW — removed from the Nasdaq symbol directory
Dermata Therapeutics, Inc. - Warrant
Aug 18, 2026
Trading halt
Halt Resumed: DRMAW — trading resumed after D (Security Deletion)
Halted 2026-08-17T20:21:31.000Z | Resumed 2026-08-18T04:00:01.000Z
Aug 17, 2026
Trading halt
Trading Halt: DRMAW — T12 (Additional Information Requested)
Dermata Therapeutics Wt | Market: NASDAQ | Code: T12 — Additional Information Requested
Aug 17, 2026
Trading halt
Trading Halt: DRMAW — D (Security Deletion)
Dermata Therapeutics Wt | Market: NASDAQ | Code: D — Security Deletion

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$25.0K
Current FY———$100.0K
Next FY———$750.0K

Short side

FINRA· Aug 14, 2026
401
shares short
-16.5%
vs prior settlement
1.0
days to cover
≈0.0%
of shares outstanding
Trading halts
Aug 17, 2026DeletionResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 18, 2026 Listing status
Delisted: DRMAW — removed from the Nasdaq symbol directory
Dermata Therapeutics, Inc. - Warrant
Jun 30, 2026 Inst.
UBS Group AG — ADD
1,804 shares ($18.00)
Jun 1, 2026 SEC
The SEC declared effective Dermata Therapeutics' S-3 shelf registration (File No. 333-291740) on May 29, 2026…
EFFECT — Impact 6/10
May 27, 2026 SEC
Dermata Therapeutics held its 2026 Annual Meeting on May 27, 2026. Stockholders approved several proposals including…
8-K — Impact 3/10
Apr 17, 2026 SEC
Analysis based on filing metadata only — document content was unavailable
DEFA14A — Impact 3/10
Sep 30, 2025 Inst.
UBS Group AG — TRIM
1,279 shares ($22.00)

SecBot reports

3 filings · 0 bullish · 1 bearish · 2 neutral
All DRMAW filing & press-release reports (3)